Ebola vaccine shows initial promise in human trial: U.S. govt agency

An experimental vaccine to prevent Ebola virus disease was well-tolerated and produced immune system responses in all 20 healthy adults who received it in a phase one clinical trial, the U.S. National Institutes of Health ( NIH) said Wednesday.

Xinhua

Xinhua

10 Years ago

North America Ebola said vaccine NIH virus